Simply Solventless Concentrates Ltd. (TSXV:HASH)
Canada · Delayed Price · Currency is CAD 0.0500
0.00 (0.00%)
Sep 16, 2026, 9:30 AM EST
TSXV:HASH Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 21.58 | 29.06 | 13.68 | 6.19 | 2.8 | 1.22 | |
Revenue Growth | -23.98% | 112.43% | 120.93% | 121.18% | 130.16% | - |
Cost of Revenue | 22.69 | 31.75 | 12.73 | 2.69 | 2.76 | 1.73 |
Gross Profit | -1.12 | -2.69 | 0.95 | 3.5 | 0.04 | -0.52 |
Selling, General & Admin | 7.82 | 8.27 | 4.4 | 1.21 | 1.13 | 1.37 |
Operating Expenses | 11.83 | 13.51 | 5.4 | 1.48 | 1.41 | 1.81 |
Operating Income | -12.95 | -16.2 | -4.45 | 2.02 | -1.37 | -2.32 |
Interest Expense | -2.67 | -2.44 | -1.47 | -0.34 | -0.26 | -0 |
Currency Exchange Gain (Loss) | -0.02 | -0.06 | -0.02 | -0.01 | -0 | - |
Other Non Operating Income (Expenses) | -0.05 | -0.14 | 0.03 | - | -0.05 | -0 |
EBT Excluding Unusual Items | -15.68 | -18.84 | -5.92 | 1.67 | -1.68 | -2.33 |
Merger & Restructuring Charges | -0.76 | -0.08 | -0.27 | -1.04 | - | - |
Impairment of Goodwill | -7.79 | -7.79 | -1.48 | - | - | - |
Gain (Loss) on Sale of Assets | 0.31 | 0.28 | - | 0.42 | - | - |
Asset Writedown | -1.73 | -1.8 | - | - | - | - |
Other Unusual Items | 0.03 | -0.16 | -0.28 | - | - | - |
Pretax Income | -25.63 | -28.39 | -7.96 | 1.04 | -1.68 | -2.33 |
Income Tax Expense | -1.07 | -1.07 | -0.34 | - | - | - |
Net Income | -24.56 | -27.33 | -7.62 | 1.04 | -1.68 | -2.33 |
Net Income to Common | -24.56 | -27.33 | -7.62 | 1.04 | -1.68 | -2.33 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 116 | 113 | 67 | 39 | 35 | 30 |
Shares Outstanding (Diluted) | 116 | 113 | 67 | 42 | 37 | 30 |
Shares Change | 19.52% | 67.78% | 60.90% | 14.02% | 20.19% | - |
EPS (Basic) | -0.21 | -0.24 | -0.11 | 0.03 | -0.05 | -0.08 |
EPS (Diluted) | -0.21 | -0.24 | -0.11 | 0.02 | -0.05 | -0.08 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 1.11 | -0.05 | -6.46 | -0.47 | -1.4 | -2.76 |
Free Cash Flow Per Share | 0.01 | - | -0.10 | -0.01 | -0.04 | -0.09 |
Gross Margin | -5.18% | -9.26% | 6.93% | 56.48% | 1.37% | -42.38% |
Operating Margin | -60.00% | -55.75% | -32.56% | 32.55% | -48.92% | -191.03% |
Profit Margin | -113.85% | -94.04% | -55.71% | 16.80% | -60.15% | -191.28% |
Free Cash Flow Margin | 5.17% | -0.17% | -47.22% | -7.55% | -50.06% | -226.97% |
EBITDA | -12.36 | -15.09 | -3.86 | 2.06 | -1.12 | -2.26 |
EBITDA Margin | -57.26% | -51.95% | -28.23% | 33.31% | -39.98% | -185.45% |
D&A For EBITDA | 0.59 | 1.1 | 0.59 | 0.05 | 0.25 | 0.07 |
EBIT | -12.95 | -16.2 | -4.45 | 2.02 | -1.37 | -2.32 |
EBIT Margin | -60.00% | -55.74% | -32.56% | 32.55% | -48.92% | -191.03% |
Revenue as Reported | 21.58 | 29.06 | 13.68 | 6.19 | - | - |